1000 resultados para 7140-323
Resumo:
The musicians are seen in daily neurological practice facing various problems sometimes simple such as skeletal or tendon pain or even compression of a nerve trunk and sometimes more complicated such as focal dystonia. Dystonia often has a dramatic impact on the career of a musician given the complexity of the clinical and therapeutic approach and the results are often disappointing. The history of the German Romantic composer Robert Schumann illustrates this reality; through his story a discussion of both the different pathophysiological hypotheses responsible for focal dystonia, a disorder of brain plasticity, and of the multimodal therapeutic approaches, revisited in the light of neurophysiological findings will be described.
Resumo:
Newsletter for Economic Development
Resumo:
BACKGROUND: Jeune asphyxiating thoracic dystrophy (JATD) is a rare, often lethal, recessively inherited chondrodysplasia characterised by shortened ribs and long bones, sometimes accompanied by polydactyly, and renal, liver and retinal disease. Mutations in intraflagellar transport (IFT) genes cause JATD, including the IFT dynein-2 motor subunit gene DYNC2H1. Genetic heterogeneity and the large DYNC2H1 gene size have hindered JATD genetic diagnosis. AIMS AND METHODS: To determine the contribution to JATD we screened DYNC2H1 in 71 JATD patients JATD patients combining SNP mapping, Sanger sequencing and exome sequencing. RESULTS AND CONCLUSIONS: We detected 34 DYNC2H1 mutations in 29/71 (41%) patients from 19/57 families (33%), showing it as a major cause of JATD especially in Northern European patients. This included 13 early protein termination mutations (nonsense/frameshift, deletion, splice site) but no patients carried these in combination, suggesting the human phenotype is at least partly hypomorphic. In addition, 21 missense mutations were distributed across DYNC2H1 and these showed some clustering to functional domains, especially the ATP motor domain. DYNC2H1 patients largely lacked significant extra-skeletal involvement, demonstrating an important genotype-phenotype correlation in JATD. Significant variability exists in the course and severity of the thoracic phenotype, both between affected siblings with identical DYNC2H1 alleles and among individuals with different alleles, which suggests the DYNC2H1 phenotype might be subject to modifier alleles, non-genetic or epigenetic factors. Assessment of fibroblasts from patients showed accumulation of anterograde IFT proteins in the ciliary tips, confirming defects similar to patients with other retrograde IFT machinery mutations, which may be of undervalued potential for diagnostic purposes.
Resumo:
The biological and therapeutic responses to hyperthermia, when it is envisaged as an anti-tumor treatment modality, are complex and variable. Heat delivery plays a critical role and is counteracted by more or less efficient body cooling, which is largely mediated by blood flow. In the case of magnetically mediated modality, the delivery of the magnetic particles, most often superparamagnetic iron oxide nanoparticles (SPIONs), is also critically involved. We focus here on the magnetic characterization of two injectable formulations able to gel in situ and entrap silica microparticles embedding SPIONs. These formulations have previously shown suitable syringeability and intratumoral distribution in vivo. The first formulation is based on alginate, and the second on a poly(ethylene-co-vinyl alcohol) (EVAL). Here we investigated the magnetic properties and heating capacities in an alternating magnetic field (141 kHz, 12 mT) for implants with increasing concentrations of magnetic microparticles. We found that the magnetic properties of the magnetic microparticles were preserved using the formulation and in the wet implant at 37 degrees C, as in vivo. Using two orthogonal methods, a common SLP (20 Wg(-1)) was found after weighting by magnetic microparticle fraction, suggesting that both formulations are able to properly carry the magnetic microparticles in situ while preserving their magnetic properties and heating capacities. (C) 2010 Elsevier B.V. All rights reserved.
Resumo:
Estudi realitzat a partir d’una estada a la University of Oxford, Gran Bretanya, entre 2010 i 2012. Durant l’estada postdoctoral a la University of Oxford s’han efectuat dos estudis relacionats amb l’onomàstica dels faraons d’Egipte i que constitueixen una continuació de l’anàlisi de la titulatura d’Alexandre el Gran realitzada prèviament per l’investigador en la seva recerca doctoral. El primer estudi examina la titulatura faraònica dels emperadors romans en comparació amb la d’Alexandre i, en especial, la significació ideològica i política dels paral•lelismes onomàstics existents entre elles, els quals han estat analitzats en el marc de la imitatio-aemulatio-comparatio Alexandri. Per al cas d’August, s’ha arribat a la conclusió que l’adopció de determinats apel•latius egipcis utilitzats anteriorment per Alexandre pot ser interpretada com un exemple local o estrictament egipci d’imitatio Alexandri, mentre que, en relació amb la resta d’emperadors, atès que les seves titulatures faraòniques es basen o imiten la del primer emperador, aquestes represes han de ser vistes més aviat com un exemple d’imitatio (o comparatio) Augusti. El segon estudi versa sobre la titulatura faraònica egípcia i la tradició annalística. A partir d’una anàlisi comparativa dels protocols onomàstics dels fundadores de cadascuna de les dinasties, s’ha intentat determinar si determinats noms o epítets s’empren de forma recurrent i d’una manera deliberada per tal de senyalar canvis dinàstics, és a dir, noves realitats polítiques. En concret, s’ha pretès establir fins a quin punt determinats recursos onomàstics tenen el seu reflex en la divisió en dinasties de Manetó i, alhora, determinar en quina mesura l’estudi de l’onomàstica faraònica pot contribuir al coneixement de com els egipcis conceptualitzaren i organitzaren el seu propi passat.
Resumo:
Collection : Comment guérir ?
Resumo:
Collection : Comment guérir ?
Resumo:
The human TPTE (Transmembrane Phosphatase with TEnsin homology) gene family encodes a PTEN-related tyrosine phosphatase with four potential transmembrane domains. Chromosomal mapping revealed multiple copies of the TPTE gene on chromosomes 13, 15, 21, 22 and Y. Human chromosomes 13 and 21 copies encode two functional proteins, TPIP (TPTE and PTEN homologous Inositol lipid Phosphatase) and TPTE, respectively, whereas only one copy of the gene exists in the mouse genome. In the present study, we show that TPTE and TPIP proteins are expressed in secondary spermatocytes and/or prespermatids. In addition, we report the existence of several novel alternatively spliced isoforms of these two proteins with variable number of transmembrane domains. The latter has no influence on the subcellular localization of these different peptides as shown by co-immunofluorescence experiments. Finally, we identify another expressed TPTE copy, mapping to human chromosome 22, whose transcription appears to be under the control of the LTR of human endogenous retrovirus RTVL-H3.